Protagenic Therapeutics, Inc. (PTIX)
0.4205
-0.05
(-10.94%)
USD |
OTCM |
Feb 20, 16:00
Protagenic Therapeutics SG&A Expense (Quarterly) : 0.1599M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biogen, Inc. | 682.50M |
| Vanda Pharmaceuticals, Inc. | 62.98M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Savara, Inc. | 9.627M |